← Back to Search

Corticosteroid

Visual Training in Control cohort for Hemianopia

N/A
Waitlist Available
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Cortically Blind participants
* Between 21 and 75 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Summary

This project aims to develop a novel visual training paradigm for use in visually-intact participants and those sufferings from stroke-induced visual impairments. Our task design is built upon theories of statistical learning to reduce the overall training burden while still producing profound improvements to visual abilities. Efficacy will be first established in visually-intact controls before testing in stroke survivors to assess the feasibility of this form of learning in the damaged visual system.

Who is the study for?
This trial is for individuals with vision loss due to stroke, including conditions like hemianopia and partial vision loss. It's open to those who have had either ischemic or hemorrhagic strokes that resulted in visual field defects. The study will first involve people without visual impairments before including stroke survivors.
What is being tested?
The trial is testing a new type of visual training based on statistical learning theories. The goal is to improve vision with less training effort. Initially, the method will be tested on people with normal vision, then on those affected by stroke-related visual issues.
What are the potential side effects?
Since this intervention involves non-invasive vision training exercises, no significant side effects are expected. However, participants may experience eye strain or fatigue from the tasks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Explicit Learning - Response Time
Implicit Learning - Triplet Familiarity

Trial Design

2Treatment groups
Experimental Treatment
Group I: Visual Training in Cortically Blind cohortExperimental Treatment1 Intervention
Group II: Visual Training in Control cohortExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
848 Previous Clinical Trials
535,397 Total Patients Enrolled
~20 spots leftby Oct 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top